These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29636964)

  • 1. Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries.
    Rivera-Rodriguez CL; Resch S; Haneuse S
    SAGE Open Med; 2018; 6():2050312118765602. PubMed ID: 29636964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved calibration estimators for the total cost of health programs and application to immunization in Brazil.
    Rivera-Rodriguez C; Toscano C; Resch S
    PLoS One; 2019; 14(3):e0212401. PubMed ID: 30840645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).
    Brenzel L; Young D; Walker DG
    Vaccine; 2015 May; 33 Suppl 1():A13-20. PubMed ID: 25919153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization.
    Castañeda-Orjuela C; Romero M; Arce P; Resch S; Janusz CB; Toscano CM; De la Hoz-Restrepo F
    Vaccine; 2013 Jul; 31 Suppl 3():C72-9. PubMed ID: 23777695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.
    Pecenka C; Munthali S; Chunga P; Levin A; Morgan W; Lambach P; Bhat N; Neuzil KM; Ortiz JR; Hutubessy R
    PLoS One; 2017; 12(12):e0190006. PubMed ID: 29281710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the cost of delivering routine immunization in Honduras.
    Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC
    Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology.
    Hendriks ME; Kundu P; Boers AC; Bolarinwa OA; Te Pas MJ; Akande TM; Agbede K; Gomez GB; Redekop WK; Schultsz C; Swan Tan S
    Glob Health Action; 2014; 7():23573. PubMed ID: 24685170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
    Mugford M; Hutton G; Fox-Rushby J
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.
    Beck EJ; Avila C; Gerbase S; Harling G; De Lay P
    Pharmacoeconomics; 2012 Oct; 30(10):887-902. PubMed ID: 22830633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates.
    Portnoy A; Vaughan K; Clarke-Deelder E; Suharlim C; Resch SC; Brenzel L; Menzies NA
    Pharmacoeconomics; 2020 Sep; 38(9):995-1005. PubMed ID: 32596785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating costing study results into district and service planning to enhance immunization programme performance: a Zambian case study.
    Feldhaus I; Schütte C; Mwansa FD; Undi M; Banda S; Suharlim C; Menzies NA; Brenzel L; Resch SC; Kinghorn A
    Health Policy Plan; 2019 Jun; 34(5):327-336. PubMed ID: 31157376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries.
    Munk C; Portnoy A; Suharlim C; Clarke-Deelder E; Brenzel L; Resch SC; Menzies NA
    BMC Health Serv Res; 2019 Oct; 19(1):741. PubMed ID: 31640687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.